These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31165753)

  • 1. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.
    Pak S; You D; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Kim CS; Ahn H
    Sci Rep; 2019 Jun; 9(1):8305. PubMed ID: 31165753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
    Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
    JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting.
    Kwon T; Jeong IG; Lee J; Lee C; You D; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):169-76. PubMed ID: 25119986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
    Guzzo TJ; Resnick MJ; Canter DJ; Balandra A; Bergey MR; Magerfleisch L; Tomaszewski JE; Vaughn DJ; Malkowicz SB
    Can J Urol; 2010 Dec; 17(6):5465-71. PubMed ID: 21172112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy.
    von Landenberg N; Speed JM; Cole AP; Seisen T; Lipsitz SR; Gild P; Menon M; Kibel AS; Roghmann F; Noldus J; Sun M; Trinh QD
    Urol Oncol; 2018 Feb; 36(2):78.e13-78.e19. PubMed ID: 29169845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification.
    Sakura Y; Yamashita R; Notsu A; Usui K; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
    Int J Urol; 2024 Jul; 31(7):785-792. PubMed ID: 38606834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.
    Lee EK; Herr HW; Dickstein RJ; Kassouf W; Munsell MF; Grossman HB; Dinney CP; Kamat AM
    BJU Int; 2012 Dec; 110(11 Pt B):E590-5. PubMed ID: 22758775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy is possibly beneficial for locally advanced or node-positive bladder cancer.
    Kanatani A; Nakagawa T; Kawai T; Naito A; Sato Y; Yoshida K; Nozaki K; Nagata M; Yamada Y; Azuma T; Suzuki M; Fujimura T; Fukuhara H; Nishimatsu H; Kume H; Igawa Y; Homma Y
    Clin Genitourin Cancer; 2015 Apr; 13(2):e107-12. PubMed ID: 25456839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Treatment Strategies and Comparison of Outcomes in Lymph Node Positive Bladder Cancer: An Analysis of the National Cancer Database.
    Darwish C; Sparks A; Amdur R; Reddy A; Whalen M
    Urology; 2020 Dec; 146():168-176. PubMed ID: 32866509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
    Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW
    Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Lymph Node Dissection in Patients With Muscle-Invasive Bladder Cancer Who Underwent Radical Cystectomy Following Neoadjuvant Chemotherapy.
    Zennami K; Takahara K; Nukaya T; Takenaka M; Ichino M; Sasaki H; Kusaka M; Sumitomo M; Shiroki R
    Clin Genitourin Cancer; 2024 Apr; 22(2):1-9. PubMed ID: 37423863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
    Kassouf W; Agarwal PK; Herr HW; Munsell MF; Spiess PE; Brown GA; Pisters L; Grossman HB; Dinney CP; Kamat AM
    J Clin Oncol; 2008 Jan; 26(1):121-6. PubMed ID: 18165646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry.
    Staník M; Poprach A; Zapletalová M; Krejčí D; Macík D; Čapák I; Jarkovský J; Lakomý R; Doležel J
    Clin Genitourin Cancer; 2019 Aug; 17(4):e759-e767. PubMed ID: 31101578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.
    Mazzone E; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Apr; 17(2):105-113.e2. PubMed ID: 30527745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
    Lucca I; Rouprêt M; Kluth L; Rink M; Tilki D; Fajkovic H; Kassouf W; Hofbauer SL; de Martino M; Karakiewicz PI; Briganti A; Trinh QD; Seitz C; Fritsche HM; Burger M; Lotan Y; Kramer G; Shariat SF; Klatte T
    BJU Int; 2015 May; 115(5):722-7. PubMed ID: 24905084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M
    Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis.
    Necchi A; Mariani L; Lo Vullo S; Yu EY; Woods ME; Wong YN; Harshman LC; Alva A; Sternberg CN; Bamias A; Grivas P; Koshkin VS; Roghmann F; Dobruch J; Eigl BJ; Nappi L; Milowsky MI; Niegisch G; Pal SK; De Giorgi U; Recine F; Vaishampayan U; Berthold DD; Bowles DW; Baniel J; Theodore C; Ladoire S; Srinivas S; Agarwal N; Crabb S; Sridhar S; Golshayan AR; Ohlmann C; Xylinas E; Powles T; Rosenberg JE; Bellmunt J; van Rhijn B; Galsky MD; Hendricksen K;
    Eur Urol Focus; 2019 Mar; 5(2):242-249. PubMed ID: 28753897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed.
    Jeong IG; Park J; Song K; Ro JY; Song C; Hong JH; Ahn H; Kim CS
    Urol Oncol; 2011; 29(2):199-204. PubMed ID: 19556153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.